Khattar Jack A.
Director
Latest Insider Transactions
9 transactions (past 365 days)
| 2026-06-22 | 2026-06-17 | CGTX Cognition Therapeutics Inc | Director | Award | 25,000 | $0.00 | $0 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 24,138 | $50.09 | $1,209,072 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Other | 12,500 | $0.00 | $0 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 10,742 | $51.00 | $547,842 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Sale | 120 | $51.75 | $6,210 |
| 2026-03-16 | 2026-03-13 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Other | 12,500 | $0.00 | $0 |
| 2026-03-10 | 2026-03-06 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Tax Payment | 16,574 | $54.73 | $907,095 |
| 2026-03-10 | 2026-03-06 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Exercise Conversion | 38,640 | $0.00 | $0 |
| 2026-02-20 | 2026-02-18 | SUPN Supernus Pharmaceuticals, Inc. | CEO | Award | 341,610 | $0.00 | $0 |
SUPN
CEO
Sale
$1.2M
24,138 shares @ $50.09
Filed 2026-03-16Trade 2026-03-13
Supernus Pharmaceuticals, Inc.SUPN
CEO
Sale
$547.8K
10,742 shares @ $51.00
Filed 2026-03-16Trade 2026-03-13
Supernus Pharmaceuticals, Inc.SUPN
CEO
Tax Payment
$907.1K
16,574 shares @ $54.73
Filed 2026-03-10Trade 2026-03-06
Supernus Pharmaceuticals, Inc.SUPN
CEO
Exercise Conversion
$0
38,640 shares @ $0.00
Filed 2026-03-10Trade 2026-03-06
Supernus Pharmaceuticals, Inc.